Related references
Note: Only part of the references are listed.Recent Approaches to Chiral 1,4-Dihydropyridines and their Fused Analogues
Martins Rucins et al.
CATALYSTS (2020)
How to Improve Effectiveness and Adherence to Antihypertensive Drug Therapy: Central Role of Dihydropyridinic Calcium Channel Blockers in Hypertension
Giuliano Tocci et al.
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION (2018)
Discovery and Development of Calcium Channel Blockers
Theophile Godfraind
FRONTIERS IN PHARMACOLOGY (2017)
Synthesis, Docking Simulation, Biological Evaluations and 3D-QSAR Study of 1,4-Dihydropyridines as Calcium Channel Blockers
Tarek Fathy El-Moselhy et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2017)
Design and synthesis of novel 4-substituted 1,4-dihydropyridine derivatives as hypotensive agents
Prasanna A. Datar et al.
JOURNAL OF SAUDI CHEMICAL SOCIETY (2016)
Pharmacology, Efficacy and Safety of Felodipine with a Focus on Hypertension and Angina Pectoris
Kinjal Navadiya et al.
CURRENT DRUG SAFETY (2015)
Long-acting dihydropyridine calcium-channel blockers and sympathetic nervous system activity in hypertension: A literature review comparing amlodipine and nifedipine GITS
Corey B. Toal et al.
BLOOD PRESSURE (2012)
Synthesis of a New Series of 4-Aryl-1,4-Dihydropyridines with Calcium Channel Blocking and Vasodilatory Activity
Ranju Bansal et al.
MEDICINAL CHEMISTRY RESEARCH (2012)
Synthesis, study of 3D structures, and pharmacological activities of lipophilic nitroimidazolyl-1,4-dihydropyridines as calcium channel antagonist
Ramin Miri et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
The new generation dihydropyridine type calcium blockers, bearing 4-phenyl oxypropanolamine, display alpha-/beta-adrenoceptor antagonist and long-acting antihypertensive activities
JC Liang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2002)
Share Paper
